Archives

Archives2020-01-16T14:10:57+01:00

GET OUR LATEST REPORTS DELIVERED TO YOUR INBOX

Welcome to our archives.  Here you will find all of our reports. The companies featured have been selected through a set of variables established by our proprietary machine learning AI and database,”Asgard”.  Asgard could thus be described as stock a selection tool that identifies high-probability fraudulent/dubious tickers and ascertains high-profitability trading entry and exit points. For more information check out our about page.

.

Watchlist Report NVAX, Novavax, Inc., January 21, 2020

January 21st, 2020|

Welcome to our first Watchlist Report, in these reports we discuss potential shorts which have not yet met the necessary conditions to be actionable. THESE REPORTS ARE NOT SHORT REPORTS. In the case of NVAX, we would not consider it a short candidate unless its price per share surpasses the $10 mark. Intro: In our first watchlist report we have Novavax (NVAX), whose remarkable price increase and record volume during today’s [...]

Cemtrex, Inc. Nasdaq: CETX Short report, January 16, 2020

January 16th, 2020|

Intro: A quick look at CETX’s price action over the last twelve months will reveal a “bumpy” downward slope. We believe the present time is yet another “bump” in this ticker’s continued yet prolonged southward trajectory. In this short report we will be analysing some of the red flags investors and traders ought to be aware of, such as: securities class action lawsuits, worsening financials, dilution and a couple of institutional shareholders [...]

CounterPath Corp. Nasdaq: CPAH Short Report, January 13, 2020

January 13th, 2020|

Intro: Another week, another short report highlighting red flags to potential investors/traders. This time around we present to you CounterPath Corp. (CPAH). CPAH popped up in our radars last Friday due to its ludicrous 300% price increase relative to Thursday’s closing price, volume exceeding 42 million shares (seven times the number of outstanding shares) and RSI (14) breaching 94. The reason touted for the drastic increase in the company’s share price was [...]

Trillium Therapeutics Inc. Nasdaq: TRIL Short Report, January 10, 2020

January 10th, 2020|

Intro: Once again, we bring to your attention a ticker that has exhibited the usual behaviour that makes us warry. TRIL’s share price saw a near 100% increase yesterday with RSI (14) exceeding 85 and volume reaching record levels by a significant margin. We will thus be taking a look at some of the red flags the company rises in order to offer a more bearish perspective. Security Details (January [...]

Inpixon Nasdaq: INPX Short Report, January 6, 2020

January 6th, 2020|

Intro: INPX short report Another week, another report on a suspicious ticker. This time we present to you Inpixon (INPX). Its share price has increased by more than ten-fold over the last three weeks, volume at all-time record levels by a significant margin and daily RSI (14) exceeds 90. INPX also raises some eyebrows when a look is taken at its share issuance practices, its lenders and the underwriter of one its latest public offerings. [...]

FuelCell Energy, Inc. Nasdaq: FCEL Short Report, January 2, 2020

January 2nd, 2020|

Intro: Like most of the tickers featured in our short reports FCEL has exhibited a combination of a drastic price increase (a near ten-fold price increase over the last 2 months), trading volume substantially above the 30-day daily average (151.5 million vs 25.7 million) and high RSI (92). One might argue that this is not a particularly strange occurrence in the world of small caps but upon further inspection we have found [...]

%d bloggers like this: